Clinicopathologic variables according to disease severity in dogs with heartworm disease Authors: Minsuk Kim, Minwoong Seo, Jaechun Cho, Chul Park Published: 2026 ABSTRACT AbstractBackgroundCanine heartworm disease is associated with various clinicopathologic abnormalities; however, most previous studies have focused on comparisons between infected and non-infected dogs rather than differences according to disease severity. The American Heartworm Society (AHS) clinical classification reflects disease severity in clinical practice, but clinicopathologic changes based on this classification have not been fully characterized. This study aimed to evaluate clinicopathologic variables according to disease severity and to assess their associations with heartworm class in dogs with heartworm disease.MethodsThis retrospective study included 35 dogs diagnosed with heartworm disease. Dogs were classified according to Amearican Heartworm Society guidelines into mild (class 1–2) and advanced (class 3–4) groups. Clinicopathologic variables, including complete blood count, electrolyte, serum chemistry, and thromboelastography (TEG) parameters, were compared between groups, and correlations with heartworm class were evaluated.ResultsA total of 35 dogs were retrospectively analyzed and categorized into mild (class 1–2, n = 17) and advanced (class 3–4, n = 18) groups. Compared with the mild group, dogs in the advanced group had significantly higher RDW, BUN, AST, CREA, and thromboelastography reaction time (R), and significantly lower Na⁺, Ca²⁺, and Cl⁻ concentrations. Spearman correlation analysis showed that heartworm class was positively correlated with RDW (ρ = 0.550), BUN (ρ = 0.601), AST (ρ = 0.788), and R (ρ = 0.730), and negatively correlated with Na⁺ (ρ = -0.430), Ca²⁺ (ρ = -0.422), and Cl− (ρ = -0.392) (all P < 0.05). CREA was significantly different between groups but was not significantly correlated with heartworm class.ConclusionsClinicopathologic variables differed according to disease severity in dogs with heartworm disease. These findings suggest that selected variables may reflect increasing clinical severity and provide adjunctive information for clinical assessment. Further studies are needed to validate these associations. Keywords: Canine, Heartworm, Complete blood count, Electrolytes, Serum biochemistry Background Canine heartworm disease is a common parasitic infection encountered in clinical practice. Heartworms are transmitted by mosquitoes and are initially located in the subcutaneous tissues and muscles; later, they migrate into the vascular system, where they may cause various complications, including eosinophilic pneumonitis, pulmonary hypertension, and caval syndrome [1]. Although clinical and cardiac evaluations are typically emphasized in dogs with heartworm disease, this condition may also influence extracardiac organs and clinicopathologic variables, supporting the inclusion of complete blood count, electrolyte, and serum chemistry analyses in the overall assessment. Furthermore, after entering the vascular system, they may compromise perfusion to various tissues and organs and contribute to clinicopathologic abnormalities, as previously reported [2]. To date, several studies have investigated clinicopathologic changes in dogs with heartworm disease [2–6]. Previous studies have described a range of clinicopathologic abnormalities in dogs with heartworm disease, including changes in red blood cell count, white blood cell count, platelet count, renal variables, liver enzyme activities, and albumin concentration [2–4, 7, 8]. However, most previous studies have focused on comparisons between dogs with and without heartworm disease, rather than differences according to disease severity within affected dogs. To date, only one study has investigated such differences, classifying dogs according to microfilarial burden [4]. Clinical-severity based evaluation may be more relevant to prognosis, monitoring, and clinical decision-making. To the authors’ knowledge, clinicopathologic findings in dogs with heartworm disease have not yet been evaluated according to the American Heartworm Society clinical classification, which reflects clinical severity and disease burden in practice [9]. Unlike microfilarial burden, the American Heartworm Society clinical classification reflects the overall clinical severity of heartworm disease and is therefore more directly relevant to prognosis and clinical decision-making. Therefore, this study aimed to evaluate clinicopathologic findings according to heartworm disease class rather than simply comparing dogs based on the presence or absence of heartworm disease. For the clinicopathologic analysis, dogs were categorized according to heartworm class, with classes 1–2 considered the mild heartworm disease group and classes 3–4 considered the advanced heartworm disease group. The aim of the present study was to determine which clinicopathologic variables increase or decrease with increasing clinical severity of heartworm disease and to evaluate their correlations with heartworm class. Methods Study design This retrospective study was based on a review of the medical records of client-owned dogs presented to the Jeonbuk National University Veterinary Teaching Hospital between July 2020 and February 2023. Owner consent for the use of clinical information was obtained at the time of presentation. Inclusion criteria consisted of a positive heartworm antigen test result obtained using a commercial assay kit (SNAP 4Dx; IDEXX Laboratories, Westbrook, ME, USA). Heartworm clinical severity was classified according to the American Heartworm Society guidelines using the information documented in the medical records. The available records variably included history, blood test results, and imaging findings, including thoracic radiography and echocardiography. Dogs were excluded if the available data were insufficient for heartworm class assignment or if concurrent systemic diseases were present. Data collection All clinicopathologic data used in this study were obtained at the time of diagnosis. Because of the retrospective nature of the study, the type and availability of collected data varied among dogs depending on the clinical situation. Therefore, the sample size differed for each variable, and the corresponding number of dogs is reported for each analysis in the results section. Blood samples were collected from either the jugular or cephalic vein, depending on patient condition and venous accessibility. Blood for complete blood count (CBC) was collected into EDTA tubes and analyzed using an automated hematology analyzer (MEK-6450; Nihon Kohden, Tokyo, Japan). Blood for electrolyte analysis was collected into heparin tubes and analyzed using an electrolyte analyzer (i-Smart 300; i-SENS, Seoul, Korea). Blood for serum biochemistry analysis was collected into serum separator tubes and analyzed using a chemistry analyzer (FUJI DRI-CHEM NX700i; FUJIFILM Corporation, Tokyo, Japan). Blood for thromboelastography (TEG) was collected into citrate tubes and analyzed using a TEG analyzer (TEG 5000; Haemonetics Corporation, Braintree, MA, USA) with kaolin-activated cups. Statistical analysis All statistical analyses were performed using RStudio (version 2024.12.1, PBC, Boston, MA, USA). Normality of continuous variables was assessed using the Shapiro–Wilk test. Depending on the results of the normality test, comparisons between groups were performed using Student’s t-test for parametric data or the Wilcoxon rank-sum test for nonparametric data. Variables in which either group contained fewer than 10 dogs were treated as nonparametric and analyzed using the Wilcoxon rank-sum test. Associations between variables were assessed using Spearman’s rank correlation coefficient. Statistical significance was set at P < 0.05. Multiple comparisons were performed across numerous clinicopathologic variables. However, given the exploratory nature of this study and the relatively small sample size, no correction for multiple testing was applied. Results A total of 35 dogs diagnosed with heartworm disease were analyzed, including 15 classified as heartworm class 1, 2 as class 2, 7 as class 3, and 11 as class 4. Mixed-breed dogs were the most common breed across all heartworm classes, accounting for 22/35 dogs overall (class 1, 11/15; class 2, 1/2; class 3, 5/7; and class 4, 5/11). The remaining dogs included Maltese (n = 2), Jindo (n = 4), Poodle (n = 2), and Husky, Spitz, Golden Retriever, Border Collie, and Doberman (n = 1 each). Body weight (BW) differed significantly between the mild and advanced heartworm groups, whereas age did not differ significantly between groups. Sex, age, and BW are summarized in Table 1. Table 1Baseline characteristics of dogs according to heartworm classClass 1 (n = 15)Class 2 (n = 2)Class 3 (n = 7)Class 4 (n = 11)Total (n = 35)Male (M)423615Castrated male (CM)20013Female (F)704314Spayed female (SF)20013Age (years)4.0 [3.0–6.0]7.5 [6.2–8.8]6.0 [5.5–7.5]6.0 [4.0–10.0]5.0 [3.5–8.5]Body weight (kg)6.0 [5.0-8.3]15.4 [11.1–19.7]21.0 [17.5–31.5]10.0 [4.9–16.4]9.1 [5.3–17.6]Data are presented as median [interquartile range] Baseline characteristics of dogs according to heartworm class Data are presented as median [interquartile range] All variables were expressed according to their distribution. Normally distributed data were presented as mean ± standard deviation, whereas non-normally distributed data were presented as median [interquartile range]. Clinicopathologic variables collected from the medical records included complete blood count (CBC), electrolyte, serum chemistry, and TEG parameters. The CBC variables included hematocrit (HCT, %), mean corpuscular volume (MCV, fL), platelet count (PLT, K/µL), red blood cell count (RBC, M/µL), red cell distribution width (RDW, %), and white blood cell count (WBC, K/µL). Electrolyte variables included sodium (Na+, mmol/L), potassium (K+, mmol/L), calcium (Ca2+, mmol/L), and chloride (Cl−, mmol/L). Serum chemistry variables included albumin (ALB, g/dL), alkaline phosphatase (ALP, U/L), alanine aminotransferase (ALT, U/L), aspartate aminotransferase (AST, U/L), blood urea nitrogen (BUN, mg/dL), creatinine (CREA, mg/dL), gamma-glutamyl transferase (GGT, U/L), globulin (GLB, g/dL), glucose (GLU, mg/dL), phosphate (PHOS, mg/dL), total bilirubin (T-BIL, mg/dL), total cholesterol (T-CHOL, mg/dL), and total protein (TPRO, g/dL). TEG variables included reaction time (R, min), clot formation time (K, min), alpha angle (α-angle, °), clot strength (G, dyn/cm²), and coagulation index (CI). In the CBC analysis, only RDW differed significantly between groups, being higher in the advanced group (13.35 [12.65–13.90]) than in the mild group (12.70 [11.90–12.90], p = 0.002), whereas HCT (44.36 ± 6.00 vs. 39.75 ± 10.40, p = 0.117), MCV (67.28 ± 4.26 vs. 64.22 ± 6.27, p = 0.100), RBC (6.64 ± 1.11 vs. 6.32 ± 2.03, p = 0.564), PLT (316.00 [239.00-360.00] vs. 178.50 [140.00-367.75], p = 0.156), and WBC (13.90 [12.40–18.20] vs. 18.45 [13.45–25.78], p = 0.080) were not significantly different. Among electrolytes, Na+ (146.64 ± 1.91 vs. 142.00 ± 6.81, p = 0.013), Ca2+ (1.36 ± 0.10 vs. 1.26 ± 0.13, p = 0.029), and Cl− (112.09 ± 4.16 vs. 106.39 ± 6.23, p = 0.007) were significantly lower in the advanced group, whereas K+ did not differ significantly (4.05 ± 0.27 vs. 4.16 ± 0.43, p = 0.405). CBC and electrolyte measurements are summarized in Table 2. In the serum chemistry analysis, CREA (0.69 ± 0.15 vs. 1.06 ± 0.58, p = 0.045), AST (24.00 [23.00-26.50] vs. 69.00 [55.00-331.00], p = 0.016), and BUN (19.10 [16.70-26.05] vs. 39.00 [23.60–80.00], p = 0.002) were significantly higher in the advanced group, while ALB (3.08 ± 0.30 vs. 2.97 ± 0.50, p = 0.506), GLB (3.19 ± 0.47 vs. 2.76 ± 0.66, p = 0.083), TPRO (6.28 ± 0.52 vs. 5.87 ± 1.11, p = 0.250), ALP (130.00 [104.50–154.00] vs. 239.50 [186.25–470.50], p = 0.130), GGT (1.00 [1.00-9.50] vs. 16.00 [4.50–36.50], p = 0.270), GLU (102.00 [94.00-112.50] vs. 102.00 [93.00-118.00], p = 0.622), PHOS (3.70 [3.45–3.75] vs. 5.65 [4.78–7.20], p = 0.071), T-BIL (0.30 [0.25–0.40] vs. 0.35 [0.18–1.55], p = 0.942), and T-CHOL (122.00 [114.50–194.00] vs. 134.00 [118.00-163.25], p = 0.943) were not significantly different. In the TEG analysis, only R was significantly prolonged in the advanced group (3.50 [3.10–5.10]) compared with the mild group (1.20 [1.00-2.20], p = 0.013), whereas K (1.00 [0.90–1.30] vs. 1.80 [1.10–3.20], p = 0.180), α-angle (76.10 [70.00-78.50] vs. 53.60 [51.40–74.80], p = 0.062), MA (73.60 [57.70–77.40] vs. 67.30 [66.60–72.70], p = 0.594), G (13900.00 [6800.00-17100.00] vs. 10300.00 [10000.00-13300.00], p = 0.594), and CI (4.25 [3.38–5.70] vs. 0.40 [0.20–4.60], p = 0.142) were not significantly different. Serum chemistry and TEG measurements are summarized in Table 3. The distributions of selected clinicopathologic variables that differ significantly between groups are shown in Fig. 1. Table 2Comparison of CBC and electrolyte measurements between mild and advanced heartworm disease groupsMild (n)MildAdvanced (n)Advancedp-valueHCT1744.36 ± 6.001839.75 ± 10.400.117MCV1767.28 ± 4.261864.22 ± 6.270.100RBC176.64 ± 1.11186.32 ± 2.030.564PLT17316.00 [239.00-360.00]18178.50 [140.00-367.75]0.156RDW1712.70 [11.90–12.90]1813.35 [12.65–13.90]0.002WBC1713.90 [12.40–18.20]1818.45 [13.45–25.78]0.080Na+11146.64 ± 1.9113142.00 ± 6.810.013K+114.05 ± 0.27134.16 ± 0.430.405Ca2+111.36 ± 0.10131.26 ± 0.130.029Cl−11112.09 ± 4.1613106.39 ± 6.230.007Data are presented as mean ± SD or median [Q1-Q3]. P-values < 0.05 were considered statistically significantHCT hematocrit, MCV mean corpuscular volume, RBC red blood cell count, PLT platelet count, RDW red cell distribution width, WBC white blood cell countNa+, sodium; K+, potassium; Ca2+, ionized calcium; Cl−, chloride Comparison of CBC and electrolyte measurements between mild and advanced heartworm disease groups Data are presented as mean ± SD or median [Q1-Q3]. P-values < 0.05 were considered statistically significant HCT hematocrit, MCV mean corpuscular volume, RBC red blood cell count, PLT platelet count, RDW red cell distribution width, WBC white blood cell count Na+, sodium; K+, potassium; Ca2+, ionized calcium; Cl−, chloride Table 3Comparison of serum chemistry and thromboelastography measurements between mild and advanced heartworm disease groupsMild (n)MildAdvanced (n)Advancedp-valueALB113.08 ± 0.3132.97 ± 0.5 0.506 CREA110.69 ± 0.15131.06 ± 0.580.045GLB113.19 ± 0.47122.76 ± 0.660.083TPRO116.28 ± 0.52135.87 ± 1.110.250ALP3130 [104.5–154]12239.5 [186.25–470.5]0.130AST324 [23-26.5]969 [55–331]0.016BUN1119.1 [16.7-26.05]1339 [23.6–80]0.002GGT31 [1-9.5]1016 [4.5–36.5]0.270GLU11102 [94-112.5]13102 [93–118]0.622PHOS33.7 [3.45–3.75]125.65 [4.78–7.2]0.071T-BIL30.3 [0.25–0.4]120.35 [0.18–1.55]0.942T-CHOL3122 [114.5–194]12134 [118-163.25]0.943R91.2 [1-2.2]53.5 [3.1–5.1]0.013K91 [0.9–1.3]51.8 [1.1–3.2]0.180α-angle976.1 [70-78.5]553.6 [51.4–74.8]0.062MA973.6 [57.7–77.4]567.3 [66.6–72.7]0.594G913,900 [6800–17100]510,300 [10000–13300]0.594CI84.25 [3.38–5.7]50.4 [0.2–4.6]0.142Data are presented as mean ± SD or median [Q1-Q3]P-values < 0.05 were considered statistically significantVariables with small sample sizes (n < 10) should be interpreted with caution due to limited statistical powerALB albumin, CREA creatinine, GLB globulin, TPRO total protein, ALP alkaline phosphatase, AST aspartate aminotransferase, BUN blood urea nitrogen, GGT gamma-glutamyl transferase, GLU glucose, PHOS phosphorus, T-BIL total bilirubin, T-CHOL total cholesterol, R reaction time, K clot formation time, α-angle alpha angle, MA maximum amplitude, G clot strength, CI coagulation index Comparison of serum chemistry and thromboelastography measurements between mild and advanced heartworm disease groups Data are presented as mean ± SD or median [Q1-Q3] P-values < 0.05 were considered statistically significant Variables with small sample sizes (n < 10) should be interpreted with caution due to limited statistical power ALB albumin, CREA creatinine, GLB globulin, TPRO total protein, ALP alkaline phosphatase, AST aspartate aminotransferase, BUN blood urea nitrogen, GGT gamma-glutamyl transferase, GLU glucose, PHOS phosphorus, T-BIL total bilirubin, T-CHOL total cholesterol, R reaction time, K clot formation time, α-angle alpha angle, MA maximum amplitude, G clot strength, CI coagulation index Distributions of selected clinicopathologic variables in mild and advanced heartworm disease groups. Jitter plots showing the distributions of selected variables that differed significantly between the mild (heartworm class 1–2) and advanced (heartworm class 3–4) groups. Variables shown include blood urea nitrogen (BUN), red cell distribution width (RDW), chloride (Cl⁻), sodium (Na⁺), aspartate aminotransferase (AST), ionized calcium (Ca²⁺), creatinine (CREA), and reaction time (R). Each dot represents one dog Spearman correlation analysis was performed only for variables that showed significant differences between the mild and advanced heartworm disease groups. Among these, HW class showed significant positive correlations with RDW (ρ = 0.550, p < 0.001), BUN (ρ = 0.601, p = 0.002), AST (ρ = 0.788, p = 0.002), and R (ρ = 0.730, p = 0.003). In contrast, HW class showed significant negative correlations with Na (ρ = -0.430, p = 0.020), Ca (ρ = -0.422, p = 0.022), and Cl− (ρ = -0.392, p = 0.035). Although CREA was significantly different between groups, it was not significantly correlated with HW class (ρ = 0.286, p = 0.175). Correlation analysis results are summarized in Table 4. Table 4Spearman correlation analysis between HW class and selected clinicopathologic variables n Spearman ρp-valueRDW 35 0.550 < 0.001 BUN240.6010.002AST120.7880.002Na+29-0.4300.020Ca2+29-0.4220.022Cl−29-0.3920.035CREA240.2860.175R140.7300.003P-values < 0.05 were considered statistically significantRDW red cell distribution width, BUN blood urea nitrogen, AST aspartate aminotransferase, Na sodium, Ca ionized calcium, Cl chloride, CREA creatinine, R reaction time Spearman correlation analysis between HW class and selected clinicopathologic variables P-values < 0.05 were considered statistically significant RDW red cell distribution width, BUN blood urea nitrogen, AST aspartate aminotransferase, Na sodium, Ca ionized calcium, Cl chloride, CREA creatinine, R reaction time Discussion In the present study, dogs were stratified according to the clinical severity of heartworm disease, following American Heartworm Society Canine Guidelines, and clinicopathologic variables were compared between groups [9]. In the comparison of baseline characteristics between the mild group (heartworm class 1–2) and the advanced group (heartworm class 3–4), body weight differed between groups, whereas age did not. This finding may reflect regional characteristics. In Korea, small-breed dogs are more commonly kept indoors and tend to receive closer routine care, whereas larger dogs in rural areas are more often kept outdoors and may receive less consistent management, including preventive care [10]. Furthermore, because Jeonbuk National University Veterinary Teaching Hospital is located in a rural area, some dogs may have been referred only after clinical signs became evident or after prolonged insufficient care, potentially influencing the characteristics and severity distribution of the study population. In the CBC analysis, RDW was the only variable that differed significantly between the mild and advanced groups (p = 0.002). Several possible explanations may account for the higher RDW observed in the advanced group. First, pulmonary hypertension may be a contributing factor. Previous studies in both humans and dogs have shown that RDW is increased in patients with pulmonary hypertension and may also be associated with prognosis [11–16]. Because the groups were classified according to the American Heartworm Society guidelines, many of the clinical features that distinguish the mild and advanced groups are closely related to pulmonary hypertension [9]. Therefore, differences in the severity of pulmonary hypertension may have contributed to the observed difference in RDW between groups. Second, mechanical stress on red blood cells may have contributed to the increased RDW. Because higher heartworm class may reflect a greater worm burden, increased intravascular parasite load could impose mechanical injury on circulating erythrocytes. Mechanical injury and hemolysis may contribute in some advanced cases, particularly in dogs with high intracardiac worm burden or caval syndrome; however, this mechanism was not directly assessed in the present study [17]. Another possible explanation is regenerative activity. Although HCT did not differ significantly between groups in the present study, it tended to be lower in the advanced group, and previous studies have reported decreased HCT in dogs with heartworm disease [2, 4, 5]. Marked regenerative activity could also increase RDW; however, because regenerative response was not evaluated in this study, this possibility could not be confirmed [18]. Other than RDW, no significant differences were identified in CBC variables between groups. This differs from some previous reports, possibly because the present study assessed differences according to disease severity within heartworm-infected dogs rather than comparing infected and non-infected populations [2–4]. Limited sample size may also have contributed to the lack of significance in other CBC variables. In the electrolyte analysis, Na+, Ca2+, and Cl− were significantly lower in the advanced group than in the mild group (p = 0.013, p = 0.03, and p = 0.007, respectively). These findings are likely to reflect the clinical condition of the dogs at the time of diagnosis rather than mechanisms specific to heartworm disease itself. Because all data were obtained at presentation, dogs in the advanced group were more likely to be clinically unstable or dehydrated. Under these conditions, activation of the renin–angiotensin system may have occurred, with subsequent antidiuretic hormone activation potentially contributing to lower Na+ and Cl− concentrations [19–21]. Ionized calcium was also lower in the advanced group, and several possible explanations can be considered for this finding. First, hypocalcemia associated with critical illness may be one possible explanation. Previous studies have reported that hypocalcemia can occur in critically ill patients [22–24]. Because advanced heartworm disease includes cases with caval syndrome, these dogs may be considered critically ill, and this may have contributed to the development of hypocalcemia. Kidney injury may also be a possible contributor. Renal-related variables, including phosphorus, were higher in the advanced group. In the setting of kidney injury, increased phosphorus may be associated with reduced calcitriol production and disruption of the PTH axis, which could ultimately contribute to decreased ionized calcium concentrations [25]. Advanced heartworm cases may benefit from electrolyte evaluation at presentation to assess their clinical status. In the chemistry analysis, BUN, AST, and CREA differed between the mild and advanced groups. The increases in BUN and CREA are consistent with findings from previous studies. For example, Kesici et al. reported significantly elevated BUN, creatinine, and liver enzyme activities (including AST and ALT) in dogs naturally infected with heartworm, supporting the presence of renal and hepatic involvement in heartworm disease [26]. Another study evaluating clinicopathologic variables in dogs with heartworm disease also reported increases in CREA, BUN, ALT, and ALP [2]. Additionally, one previous report showed that renal variables decreased after adulticide treatment [8]. Taken together, previous reports and the present findings suggest that renal variables may not be increased in the early stage of heartworm disease in dogs, but may rise as disease severity progresses [27]. One possible mechanism is glomerular injury associated with heartworm disease. Previous studies have documented proteinuria and evidence consistent with glomerular involvement in infected dogs, and experimental work has also demonstrated renal microcirculatory and histologic changes, including glomerulonephritis [27, 28]. Renal congestion associated with pulmonary hypertension may also contribute, and heartworm disease itself may predispose affected dogs to thromboembolic or ischemic renal injury, further worsening renal function. In addition, increased renal variables may reflect prerenal azotemia in dogs with caval syndrome. AST was also higher in the advanced group than in the mild group. Although this increase could reflect hepatic congestion, consideration of the other hepatic variables suggests that hemolysis associated with advanced heartworm disease may be a more likely explanation [29]. In the TEG analysis, only the R value was increased. Although the number of dogs that underwent TEG analysis was small and the statistical power was therefore limited, one possible explanation is that dogs in the advanced group may have experienced a prolonged hypercoagulable state, leading to consumption of coagulation factors and subsequent prolongation of the R time. Heartworm disease has been associated with altered hemostatic status, including hypercoagulability and decreased fibrinolysis; therefore, the prolonged R observed here may reflect coagulation disturbances in advanced disease, although this interpretation should be made cautiously given the small number of dogs undergoing TEG analysis [30, 31]. In the correlation analysis, AST and R were the only variables with a Spearman’s rho greater than 0.7. Although both variables were evaluated in a limited number of dogs, which reduces statistical power, their stronger correlations may reflect the larger numerical differences observed between the mild and advanced groups compared with other significant variables. In other words, when these variables were abnormal, the magnitude of change appeared to be more pronounced, which may have been captured in the correlation analysis. This study has several limitations. First, due to its retrospective design, no formal sample size calculation was performed prior to data collection, and the overall sample size was relatively small. This limitation may have reduced statistical power and increased the risk of both type I and type II errors. In addition, multiple comparisons were performed without adjustment for multiple testing, which may have increased the risk of type I error. Therefore, these findings should be interpreted cautiously and validated in future studies with larger sample sizes. Second, the cases were not controlled, and only data obtained at the time of diagnosis were analyzed, which may have introduced variability related to clinical status at presentation. Third, some variables other than the core dataset were available in only a small number of dogs and should therefore be interpreted cautiously. Although dogs with heartworm class 3 and 4 were combined into a single advanced group in this study, class 4 dogs often present with more severe clinical manifestations, such as caval syndrome, which may differ substantially from class 3 disease. Therefore, the inclusion of both classes within a single group may have introduced heterogeneity and influenced the results. Due to the limited number of class 3 cases, subgroup analysis was not performed; however, this should be considered in future studies. In addition, information regarding previous heartworm preventive use, history of preventive interruption, and prior heartworm antigen test results was not consistently available in the medical records. Therefore, the duration of heartworm infection before presentation could not be estimated. Because infection duration may influence clinical severity and clinicopathologic abnormalities, this factor may have affected the study results and should be evaluated in future prospective studies. Finally, heartworm class does not necessarily reflect the actual heartworm burden, which should be considered when interpreting the results. Conclusion To the authors’ knowledge, this is among the first studies to evaluate a broad panel of clinicopathologic variables according to American Heartworm Society-based clinical severity. This approach provides clinically relevant insight into how laboratory findings may vary with disease severity. This study suggests that several clinicopathologic variables, particularly RDW, renal variables, AST, and selected electrolyte abnormalities, may reflect increasing clinical severity in dogs with heartworm disease. However, further studies are warranted to enable more detailed and comprehensive evaluation of these associations. Acknowledgements Not applicable. Abbreviations Albumin Alkaline phosphatase Alanine aminotransferase Aspartate aminotransferase Blood urea nitrogen Ionized calcium Complete blood count Coagulation index Chloride Creatinine Clot strength Gamma-glutamyl transferase Globulin Glucose Hematocrit Heartworm Clot formation time Potassium Maximum amplitude Mean corpuscular volume Sodium Phosphorus Platelet count Reaction time Red blood cell count Red cell distribution width Thromboelastography Total bilirubin Total cholesterol Total protein White blood cell count Alpha angle Authors’ contributions MSK drafted the manuscript and performed the statistical analyses. MWS collected the data and contributed to the study concept and design. JCJ contributed to drafting and revising the manuscript. CP supervised the study, provided overall guidance, and approved the final version of the manuscript. All authors read and approved the final manuscript. Funding Not applicable. Data availability The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate Informed owner consent for the use of clinical data was obtained at the time of presentation. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Minsuk Kim and Minwoong Seo contributed equally to this work and share the first authorship. References Associated Data Data Availability Statement The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.